Showing results (541-550 of 991) with videos related to
Sort By:
Pageof 100
Therapeutic Advances in Respiratory Disease|May 16, 2009
Use of dry powder inhalers in acute exacerbations of asthma and COPDOlof Selroos, Lars Borgström, Jarl IngelfTherapeutic Advances in Respiratory Disease|September 4, 2016
Factors associated with experience of fatigue, and functional limitations due to fatigue in patients with stable COPDMagnus Kentson, Kristina Tödt, Elisabeth Skargren, et al.Therapeutic Advances in Respiratory Disease|September 3, 2016
End-of-life care in patients with advanced lung cancerRichard B L LimTherapeutic Advances in Respiratory Disease|June 16, 2017
Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infectionJames Greenwood, Carsten Schwarz, Urte Sommerwerck, et al.Therapeutic Advances in Respiratory Disease|January 7, 2010
Phosphatidylinositol 3-kinase isoforms as targets in respiratory diseaseJohn A Marwick, Kian Fan Chung, Ian M AdcockTherapeutic Advances in Respiratory Disease|July 8, 2017
Reslizumab in the treatment of inadequately controlled asthma in adults and adolescents with elevated blood eosinophils: clinical trial evidence and future prospectsJorge MásperoTherapeutic Advances in Respiratory Disease|June 3, 2018
Efficacy and safety of fluticasone propionate/formoterol fumarate in pediatric asthma patients: a randomized controlled trialAnna Płoszczuk, Miroslava Bosheva, Kay Spooner, et al.Therapeutic Advances in Respiratory Disease|June 6, 2018
Noninvasive ventilation and respiratory physical therapy reduce exercise-induced bronchospasm and pulmonary inflammation in children with asthma: randomized clinical trialMaisi Muniz Cabral David, Evelim Leal de Freitas Dantas Gomes, Maryjose Carvalho Mello, et al.Therapeutic Advances in Respiratory Disease|April 17, 2023
Effect of coronaviruses on blood vessel permeability: potential therapeutic targetsNicolle R Machado, Karina T Dias, Bryan F S Cortes, et al.Therapeutic Advances in Respiratory Disease|March 30, 2021
The value of imaging and clinical outcomes in a phase II clinical trial of a lysophosphatidic acid receptor antagonist in idiopathic pulmonary fibrosisGrace Hyun J Kim, Jonathan G Goldin, Wendy Hayes, et al.Pageof 100